Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Regeneron Pharmaceuticals (NQ:REGN)

542.52 -7.48 (-1.36%)
Streaming Delayed Price Updated: 4:00 PM EDT, Jul 18, 2025 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 1,307,873
Open 550.00
Bid (Size) 540.01 (1)
Ask (Size) 550.00 (1)
Prev. Close 550.00
Today's Range 541.50 - 550.88
52wk Range 476.49 - 1,211.20
Shares Outstanding 91,779,465
Dividend Yield 0.32%
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News
How Is The Market Feeling About Regeneron Pharmaceuticals?
Via Benzinga
1 Healthcare Stock on Our Buy List and 2 to Brush Off
Personal health and wellness is one of the many secular tailwinds for healthcare companies. Despite the rosy long-term prospects, short-term headwinds such as COVID inventory destocking have harmed the... 
Via StockStory
Topics Stocks

Performance

YTD
-24.1%
-24.1%
1 Month
+6.6%
+6.6%
3 Month
-3.7%
-3.7%
6 Month
-21.7%
-21.7%
1 Year
-50.0%
-50.0%

More News

Read More
Trump Threatens 200% Pharma Tariffs, But Analyst Says This Stock Is Immune And Expected To 'Benefit' From Levies
Via Benzinga
Topics Government World Trade
Assessing Regeneron Pharmaceuticals: Insights From 26 Financial Analysts
Via Benzinga
1 Cash-Heavy Stock to Own for Decades and 2 to Ignore
Via StockStory
23andMe’s $305M Sale To Co-Founder Wojcicki Approved: California Loses Legal Battle Over DNA Privacy
Via Stocktwits
Topics Bankruptcy
Apogee Reverses Lower Despite Promise For Twice-Yearly Eczema Shot
Via Investor's Business Daily
Precision Genetic Medicine Platform Could Disrupt Standard of Care in Metastatic Cancer, Other Indications of Unmet Needs
Via Investor Brand Network
Precision Genetic Medicine Platform Could Disrupt Standard of Care in Metastatic Cancer, Other Indications of Unmet Needs
Via FinancialNewsMedia
Topics Death
2 Beaten-Down Stocks to Buy and Hold
Via The Motley Fool
Topics Death
REGENERON PHARMACEUTICALS (NASDAQ:REGN) - A Potential Undervalued Biotech Stock
Via Chartmill
Regeneron's Lynozyfic Gains Accelerated FDA Approval For Heavily Pre-Treated Multiple Myeloma
Via Benzinga
Regeneron’s Therapy For Blood Cancer Bags FDA Approval: REGN Stock Jumps
Via Stocktwits
Topics Death
Lynozyfic™ (linvoseltamab-gcpt) Receives FDA Accelerated Approval for Treatment of Relapsed or Refractory Multiple Myeloma
From Regeneron Pharmaceuticals, Inc.
Via GlobeNewswire
Here's How Much $100 Invested In Regeneron Pharmaceuticals 20 Years Ago Would Be Worth Today
Via Benzinga
Regeneron Pharmaceuticals Unusual Options Activity For July 01
Via Benzinga
Nektar Jumps 157% on Drug Trial Data—Can It Go Even Higher?
Via MarketBeat
Regeneron to Report Second Quarter 2025 Financial and Operating Results and Host Conference Call and Webcast on August 1, 2025
From Regeneron Pharmaceuticals, Inc.
Via GlobeNewswire
1 Profitable Stock for Long-Term Investors and 2 to Question
Via StockStory
Why Is Nektar Therapeutics Stock Trading Higher On Wednesday?
Via Benzinga
Regeneron Announces First-of-its-Kind Donation Matching Program with Independent Charitable Patient Assistance Organization
From Regeneron Pharmaceuticals, Inc.
Via GlobeNewswire
Q1 Rundown: Regeneron (NASDAQ:REGN) Vs Other Immuno-Oncology Stocks
Via StockStory
Topics Artificial Intelligence
$100 Invested In Regeneron Pharmaceuticals 20 Years Ago Would Be Worth This Much Today
Via Benzinga
FDA Approves Regeneron Sanofi Treatment For Rare Autoimmune Skin Disorder
Via Benzinga
Regeneron, Sanofi Say Their Inflammation Drug Approved By FDA For Rare Skin Disease Affecting Elderly, But Retail Stays Dull
Via Stocktwits
Topics Supply Chain

Frequently Asked Questions

Is Regeneron Pharmaceuticals publicly traded?
Yes, Regeneron Pharmaceuticals is publicly traded.
What exchange does Regeneron Pharmaceuticals trade on?
Regeneron Pharmaceuticals trades on the Nasdaq Stock Market
What is the ticker symbol for Regeneron Pharmaceuticals?
The ticker symbol for Regeneron Pharmaceuticals is REGN on the Nasdaq Stock Market
What is the current price of Regeneron Pharmaceuticals?
The current price of Regeneron Pharmaceuticals is 542.52
When was Regeneron Pharmaceuticals last traded?
The last trade of Regeneron Pharmaceuticals was at 07/18/25 04:00 PM ET
What is the market capitalization of Regeneron Pharmaceuticals?
The market capitalization of Regeneron Pharmaceuticals is 49.79B
How many shares of Regeneron Pharmaceuticals are outstanding?
Regeneron Pharmaceuticals has 50B shares outstanding.
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms Of Service.